BioCentury
ARTICLE | Finance

Seroba’s shift

Why Seroba is aiming for larger mix of biotech investments with new fund

February 11, 2017 2:36 AM UTC
O’Connell told BioCentury the fund will make at least 10 investments and target a 3x return.

Seroba Life Sciences is planning to bump up the share of investments dedicated to biotech with its new fund to meet the demand for biotech assets from potential buyers.

The firm announced the first close of Seroba Life Sciences Fund III on Feb. 2 at €100 million ($107.5 million) with participation from existing LPs Enterprise Ireland and the Ireland Strategic Investment Fund, as well as new LP European Investment Fund (EIF). ...